Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Olk (NPI 1265429245)

Field	Value
Entity Type	Individual
Organization	Robert Olk
Address	11710 Old Ballas Rd
City	Saint Louis
State	MO
ZIP	63141
Taxonomy	Ophthalmology Physician
NPI Enumerated	October 4, 2005

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

ROBERT OLK is an ophthalmology physician in SAINT LOUIS, MO with an NPI enumerated 2005-10-04 (~21 years ago). His lifetime Medicare revenue on file is $1.7M and there is no Medicaid billing on file, indicating the provider’s public-payer footprint is effectively single‑payer Medicare at the claims level. The long enumeration date suggests an established billing history in the Medicare program.

Revenue for this provider is highly concentrated in a small set of drug administration codes: the precomputed top 3 Medicare codes account for 59.2% of total Medicare revenue. Those top three are J2777 ($478.5K, 26.9%), J2403 ($301.6K, 17.0%), and J3490 ($272.4K, 15.3%), which together drive the majority of Medicare dollars reported for this NPI. This concentration signals reliance on a few high‑value services for overall revenue.

The code mix is consistent with a retina‑focused ophthalmology practice that delivers intravitreal drug therapy and performs retina procedures and imaging. High‑revenue drug administration codes such as J2777 (faricimab) and Q5124 (ranibizumab biosimilar, $195.8K, 11.0%) appear alongside retina surgery codes including 67028 (675 claims, $70.9K) and 67040 (34 claims, $19.2K), as well as diagnostic imaging codes like 92134 (1K claims, $28.3K). This blend of biologic/drug injections, procedural intervention, and retinal imaging supports a practice model centered on medical and surgical retina care.

Competitive standing against national Medicare peers is mixed by code: J2777 is in the middle of the national distribution, ranking #659 of 2039 providers nationally (68th percentile; typical, unremarkable volume for this code), while J2403 ranks #6 of 76 providers nationally (93th percentile; typical, unremarkable volume for this code), indicating unusually high relative use of J2403 compared with most peers. J3490 ranks #422 of 2838 providers nationally (85th percentile; typical, unremarkable volume for this code). Separately, a few specialized codes show standout positions: J3396 ranks #1 of 7 providers nationally (100th percentile; notably above typical national volume for this code) and 67221 also ranks #1 of 7 providers nationally (100th percentile; notably above typical national volume for this code), indicating above‑typical volumes on these less common services.

Despite multiple drug codes appearing in the top 25, some injectable biologic codes show limited relative activity: J0178 (aflibercept) appears with 52 claims and $36.2K revenue and is ranked #3148 of 3204 providers nationally (2th percentile; typical, unremarkable volume for this code), and J7312 (dexamethasone implant) is ranked #442 of 492 providers nationally (9th percentile; typical, unremarkable volume for this code). These rankings suggest the provider uses a narrower portfolio of biologics heavily (e.g., J2777, Q5124, J2403) while other common agents are used much less compared with national peers.

Operationally, the practice generates relatively more revenue from procedure and drug administration codes than from evaluation and management visits: 99213 appears with 411 claims and $25.1K revenue (1.4% of Medicare revenue), whereas large single‑line drug codes such as J2777 and J2403 contribute disproportionately to total dollars. Imaging codes (92134: 1K claims, $28.3K; 92242: 99 claims, $19.9K) and procedure codes for vitreoretinal surgery (e.g., 67028, 67036) further indicate a service mix where procedural and pharmaceutical reimbursement outweigh routine E&M revenue.

The absence of any Medicaid billing on file (noted as “none below”) means payer mix is effectively concentrated in Medicare for the dataset provided; this limits visibility into state Medicaid-facing volume and suggests the provider either does not participate in Medicaid or did not bill Medicaid under this NPI during the reporting window. For payers and network planners, this single‑payer footprint should be treated as an operational characteristic when considering access, reimbursement negotiations, or network completeness in Medicaid populations.

From a revenue‑risk perspective, dependence on a few high‑revenue drug codes (top 3 = 59.2% of Medicare revenue) makes the provider’s Medicare income sensitive to shifts in drug utilization, biosimilar adoption, and reimbursement policy for intravitreal agents. Payers and contracting teams should flag J2777, J2403, Q5124, and related intravitreal administration activity for monitoring because changes to reimbursement rates or prescribing patterns could materially affect this provider’s Medicare revenue stream.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

41 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	16,500	$30	$478.5K
J2403	Chloroprocaine hcl ophthalmic, 3% gel, 1 mg	301,600	$1	$301.6K
J3490	Unclassified drugs	160	$1,660	$272.4K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	1,130	$170	$195.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	930	$120	$111.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	680	$110	$70.9K
J3396	Injection, verteporfin, 0.1 mg	7,650	$10	$68.8K
J0178	Injection, aflibercept, 1 mg	50	$700	$36.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,010	$30	$28.3K
67113	The provider repairs a complicated detached retina. He removes vitreous humor, the gelatinous material that gives shape to the eye, and peels the retinal membrane. He reattaches the retina with…	30	$1,000	$25.9K

Showing 1–10 of 41

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 41 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Robert Olk — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

41 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	60	60	820	$690	$683.3K
J2777	16	50	11,730	$30	$388.9K
Q5124	1	10	680	$170	$110.5K
67028	36	80	600	$90	$69.7K
J3396	1	10	7,650	$10	$67.9K
J2781	1	10	650	$120	$65.4K
J2403	1	10	82,800	$1	$55K
67040	2	10	30	$1,000	$38.1K
J7312	10	10	170	$160	$33.8K
92242	2	10	70	$190	$27.9K

Showing 1–10 of 41

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Olk, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mcv Associated Physicians	VA	Anesthesiology Physician	$0	$99M
University Of Virginia Physicians Group	VA	Sports Medicine (Neuromusculoskeletal Medicine) Physician	$0	$84.6M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Nu-crown, LLC	IL	Optometrist	$0	$5.8M
Levent Akduman	MO	Ophthalmology Physician	$3.1M	$1.4M
Ashley Blurton	VA	Nuclear Medicine Physician	$2.9M	$0
Ankit Desai	IL	Retina Specialist (Ophthalmology) Physician	$1.7M	$119.2K
Anthony Debeus	CA	Retina Specialist (Ophthalmology) Physician	$1.6M	$0
Roger Adler	IL	Ophthalmology Physician	$362.1K	$1.2M
Blonie Dudney	MO	Retina Specialist (Ophthalmology) Physician	$1.5M	$42.7K

Nearby Providers

Other providers in the same ZIP code as Robert Olk, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Hospitals East Communities	MO	General Acute Care Hospital	$0	$56.5M
Bayada Home Health Care, Inc.	MO	Home Health Agency	$0	$41.2M
Mercy Clinic East Communities	MO	Internal Medicine Physician	$0	$22.2M
Excel Home Care, Inc.	MO	Home Health Agency	$0	$19.8M
Biotech X-ray Inc	MO	Portable X-ray and/or Other Portable Diagnostic Imaging Supplier	$5.1M	$6M
Western Anesthesiology Associates, Inc.	MO	Anesthesiology Physician	$0	$10.9M
Team Select Home Care Of Missouri, Inc.	MO	Nursing Care Agency	$0	$10.7M
Physician Groups Lc	MO	Multi-Specialty Clinic/Center	$0	$9.8M
Sensory Solutions, LLC	MO	Occupational Therapist	$0	$7.3M
Excel Home Care, Inc.	MO	Home Health Agency	$0	$6.2M

Robert Olk — Billing Profile & Reimbursement Data

Sign up for Robert Olk — Billing Profile & Reimbursement Data policy alerts

Robert Olk — Billing Profile & Reimbursement Data

Sign up for Robert Olk — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References